Access Bio

Access Bio is a biotech company in Somerset, United States, founded in 2001. It has 1 recorded funding round, most recently a Venture Round in May 2011.

A trusted partner in global health

Employees
51–200
Founded
2001
Business Model
B2B
Last Round
Venture RoundMay 2011
Rounds
1

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Access Bio, Inc. (KOSDAQ: 950130) is a New Jersey-based in vitro diagnostics company dedicated to the prevention and early diagnosis of infectious diseases through the development, manufacturing, and marketing of rapid diagnostic tests (RDTs). Founded in 2001 (incorporated 2002), Access Bio developed the widely used CareStart™ product line, which includes rapid tests for malaria, G6PD deficiency, HIV, HPV, and COVID-19. The company is a trusted partner to international public health agencies, NGOs, and governments fighting malaria and other infectious diseases in developing countries, with a global reach spanning sub-Saharan Africa, Asia, and Latin America. Access Bio operates manufacturing facilities and is listed on the Korean KOSDAQ exchange. It has received investment from the Global Health Investment Fund, reflecting its mission alignment with global health impact.

Summary

It lists 51–200 employees. Its most recent funding was a Venture Round in May 2011.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundMay 2011

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Access Bio on Indexed.vc
<a href="https://indexed.vc/companies/access-bio"><img src="https://indexed.vc/api/badge/company/access-bio" alt="Access Bio on Indexed.vc" width="260" height="76" /></a>